DEFA4 and bacterial infectious disease with sepsis: Further, Defa4 possesses anti-inflammatory activity on human blood leukocytes and human THP-1 monocytic cells in vitro and can ameliorate bacterial sepsis in vivo (personal communication from A. Ouellette).